A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study ; volume:19 ; number:1 ; day:28 ; month:11 ; year:2024 ; pages:1-16 ; date:12.2024
Orphanet journal of rare diseases ; 19, Heft 1 (28.11.2024), 1-16, 12.2024
- Creator
-
Pereira, Alessandra
Fischinger Moura de Souza, Carolina
Álvarez-Córdoba, Mónica
Reche-López, Diana
Sánchez-Alcázar, José Antonio
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13023-024-03453-x
- URN
-
urn:nbn:de:101:1-2502132142549.569599502576
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pereira, Alessandra
- Fischinger Moura de Souza, Carolina
- Álvarez-Córdoba, Mónica
- Reche-López, Diana
- Sánchez-Alcázar, José Antonio
- SpringerLink (Online service)
Other Objects (12)
A therapeutic approach to pantothenate kinase associated neurodegeneration
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic kinase inhibitors
Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
A therapeutic approach to pantothenate kinase associated neurodegeneration
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic kinase inhibitors
Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey
A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies
A therapeutic approach to pantothenate kinase associated neurodegeneration
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
Resting state networks alteration in pantothenate-kinase associated neurodegeneration (PKAN)
Case report: MR spectroscopy in pantothenate kinase-2 associated neurodegeneration
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregation
Therapeutic kinase inhibitors
Pilot trial on the efficacy and safety of pantethine in children with pantothenate kinase-associated neurodegeneration: a single-arm, open-label study
Patient and caregiver experiences with pantothenate kinase-associated neurodegeneration (PKAN): results from a patient community survey